Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Sand

Showing results (101-110 of 158) with videos related to

Pageof 16
Sort By:
The Journal of Sexual Medicine|January 21, 2006
The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunctionWilliam A Fisher, Raymond C Rosen, Ian Eardley, et al.
Journal of Biomedical Optics|September 24, 2005
Comparison of histometric data obtained by optical coherence tomography and routine histologyThilo Gambichler, Stefanie Boms, Markus Stücker, et al.
International Seminars in Surgical Oncology : ISSO|July 4, 2007
Simultaneous ectopic adrenocorticotropic hormone syndrome and adrenal metastasis of a medullary thyroid carcinoma causing paraneoplastic Cushing's syndromeMichael Sand, Samuel Uecker, Falk G Bechara, et al.
The Journal of Dermatology|February 14, 2006
Polyglandular autoimmune syndrome associated with pigmented basal cell carcinomaMichael Sand, Falk Georges Bechara, Daniel Sand, et al.
Patient Related Outcome Measures|June 28, 2017
Initial development of a patient-reported outcome measure of experience with cognitive impairment associated with schizophreniaLisa C Welch, Jeremiah J Trudeau, Steven M Silverstein, et al.
Drug Discovery Today|May 4, 2023
A new era for schizophrenia drug development - Lessons for the futureKiri T Granger, Michael Sand, Sheryl Caswell, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 28, 2006
Erbium:YAG laser-assisted preparation of a combined dermal/full thickness sandwich skin graftFalk G Bechara, Michael Sand, Michael Radenhausen, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|March 24, 2017
A pilot study of quality of life in German prehospital emergency care physiciansMichael Sand, Schapoor Hessam, Falk G Bechara, et al.
Journal of Dermatological Science|February 12, 2017
Expression of oncogenic miR-17-92 and tumor suppressive miR-143-145 clusters in basal cell carcinoma and cutaneous squamous cell carcinomaMichael Sand, Schapoor Hessam, Susanne Amur, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 4, 2021
Symptomatic and preventive effects of the novel phosphodiesterase-9 inhibitor BI 409306 in an immune-mediated model of neurodevelopmental disordersJoseph Scarborough, Daniele Mattei, Cornelia Dorner-Ciossek, et al.
Pageof 16

Showing results (101-110 of 158) with videos related to

Sort By:
Pageof 16
The Journal of Sexual Medicine|January 21, 2006
The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunctionWilliam A Fisher, Raymond C Rosen, Ian Eardley, et al.
Journal of Biomedical Optics|September 24, 2005
Comparison of histometric data obtained by optical coherence tomography and routine histologyThilo Gambichler, Stefanie Boms, Markus Stücker, et al.
International Seminars in Surgical Oncology : ISSO|July 4, 2007
Simultaneous ectopic adrenocorticotropic hormone syndrome and adrenal metastasis of a medullary thyroid carcinoma causing paraneoplastic Cushing's syndromeMichael Sand, Samuel Uecker, Falk G Bechara, et al.
The Journal of Dermatology|February 14, 2006
Polyglandular autoimmune syndrome associated with pigmented basal cell carcinomaMichael Sand, Falk Georges Bechara, Daniel Sand, et al.
Patient Related Outcome Measures|June 28, 2017
Initial development of a patient-reported outcome measure of experience with cognitive impairment associated with schizophreniaLisa C Welch, Jeremiah J Trudeau, Steven M Silverstein, et al.
Drug Discovery Today|May 4, 2023
A new era for schizophrenia drug development - Lessons for the futureKiri T Granger, Michael Sand, Sheryl Caswell, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 28, 2006
Erbium:YAG laser-assisted preparation of a combined dermal/full thickness sandwich skin graftFalk G Bechara, Michael Sand, Michael Radenhausen, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|March 24, 2017
A pilot study of quality of life in German prehospital emergency care physiciansMichael Sand, Schapoor Hessam, Falk G Bechara, et al.
Journal of Dermatological Science|February 12, 2017
Expression of oncogenic miR-17-92 and tumor suppressive miR-143-145 clusters in basal cell carcinoma and cutaneous squamous cell carcinomaMichael Sand, Schapoor Hessam, Susanne Amur, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 4, 2021
Symptomatic and preventive effects of the novel phosphodiesterase-9 inhibitor BI 409306 in an immune-mediated model of neurodevelopmental disordersJoseph Scarborough, Daniele Mattei, Cornelia Dorner-Ciossek, et al.
Pageof 16